867 related articles for article (PubMed ID: 25595718)
21. Unravelling the grey zone: cardiac MRI volume to wall mass ratio to differentiate hypertrophic cardiomyopathy and the athlete's heart.
Luijkx T; Cramer MJ; Buckens CF; Zaidi A; Rienks R; Mosterd A; Prakken NH; Dijkman B; Mali WP; Velthuis BK
Br J Sports Med; 2015 Nov; 49(21):1404-9. PubMed ID: 23770661
[TBL] [Abstract][Full Text] [Related]
22. Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete's heart from pathologic hypertrophy.
Pelliccia A; Maron MS; Maron BJ
Prog Cardiovasc Dis; 2012; 54(5):387-96. PubMed ID: 22386289
[TBL] [Abstract][Full Text] [Related]
23. Electrocardiograms in athletes: interpretation and diagnostic accuracy.
Lawless CE; Best TM
Med Sci Sports Exerc; 2008 May; 40(5):787-98. PubMed ID: 18408622
[TBL] [Abstract][Full Text] [Related]
24. Sudden cardiac death in athletes and the value of cardiovascular magnetic resonance.
Mavrogeni SI; Bacopoulou F; Apostolaki D; Chrousos GP
Eur J Clin Invest; 2018 Jul; 48(7):e12955. PubMed ID: 29782639
[TBL] [Abstract][Full Text] [Related]
25. Is there evidence for mandating electrocardiogram as part of the pre-participation examination?
Borjesson M; Dellborg M
Clin J Sport Med; 2011 Jan; 21(1):13-7. PubMed ID: 21200165
[TBL] [Abstract][Full Text] [Related]
26. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death.
La Gerche A; Baggish AL; Knuuti J; Prior DL; Sharma S; Heidbuchel H; Thompson PD
JACC Cardiovasc Imaging; 2013 Sep; 6(9):993-1007. PubMed ID: 24029371
[TBL] [Abstract][Full Text] [Related]
27. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy.
Rowin EJ; Maron BJ; Appelbaum E; Link MS; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Maron MS
Am J Cardiol; 2012 Oct; 110(7):1027-32. PubMed ID: 22809754
[TBL] [Abstract][Full Text] [Related]
28. Are the QRS duration and ST depression cut-points from the Seattle criteria too conservative?
Dunn T; Abdelfattah R; Aggarwal S; Pickham D; Hadley D; Froelicher V
J Electrocardiol; 2015; 48(3):395-8. PubMed ID: 25796099
[TBL] [Abstract][Full Text] [Related]
29. 12-lead ECG in the athlete: physiological versus pathological abnormalities.
Corrado D; Biffi A; Basso C; Pelliccia A; Thiene G
Br J Sports Med; 2009 Sep; 43(9):669-76. PubMed ID: 19734501
[TBL] [Abstract][Full Text] [Related]
30. Comparison of three ECG criteria for athlete pre-participation screening.
Pickham D; Zarafshar S; Sani D; Kumar N; Froelicher V
J Electrocardiol; 2014; 47(6):769-74. PubMed ID: 25155389
[TBL] [Abstract][Full Text] [Related]
31. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification.
Maron BJ
Cardiol Clin; 2007 Aug; 25(3):399-414, vi. PubMed ID: 17961794
[TBL] [Abstract][Full Text] [Related]
32. [The ECG of athletes].
Löllgen H
Herzschrittmacherther Elektrophysiol; 2015 Sep; 26(3):274-90. PubMed ID: 26260682
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.
Corrado D; Pelliccia A; Bjørnstad HH; Vanhees L; Biffi A; Borjesson M; Panhuyzen-Goedkoop N; Deligiannis A; Solberg E; Dugmore D; Mellwig KP; Assanelli D; Delise P; van-Buuren F; Anastasakis A; Heidbuchel H; Hoffmann E; Fagard R; Priori SG; Basso C; Arbustini E; Blomstrom-Lundqvist C; McKenna WJ; Thiene G;
Eur Heart J; 2005 Mar; 26(5):516-24. PubMed ID: 15689345
[TBL] [Abstract][Full Text] [Related]
34. Sudden cardiac death in young athletes. Causes, athlete's heart, and screening guidelines.
Drezner JA
Postgrad Med; 2000 Oct; 108(5):37-44, 47-50. PubMed ID: 11043079
[TBL] [Abstract][Full Text] [Related]
35. The athlete's heart: remodeling, electrocardiogram and preparticipation screening.
Pelliccia A; Di Paolo FM; Maron BJ
Cardiol Rev; 2002; 10(2):85-90. PubMed ID: 11895574
[TBL] [Abstract][Full Text] [Related]
36. Examining QRS amplitude criteria for electrocardiographic left ventricular hypertrophy in recommendations for screening criteria in athletes.
Singla V; Jindal A; Pargaonkar V; Soofi M; Wheeler M; Froelicher V
J Electrocardiol; 2015; 48(3):368-72. PubMed ID: 25661864
[TBL] [Abstract][Full Text] [Related]
37. Discrimination of the "Athlete's Heart" from real disease by electrocardiogram and echocardiogram.
Erickson CC
Cardiol Young; 2017 Jan; 27(S1):S80-S88. PubMed ID: 28084953
[TBL] [Abstract][Full Text] [Related]
38. Assessment of left atrial function in hypertrophic cardiomyopathy and athlete's heart: a left atrial myocardial deformation study.
Gabrielli L; Enríquez A; Córdova S; Yáñez F; Godoy I; Corbalán R
Echocardiography; 2012 Sep; 29(8):943-9. PubMed ID: 22954405
[TBL] [Abstract][Full Text] [Related]
39. ECG-derived spatial QRS-T angle is strongly associated with hypertrophic cardiomyopathy.
Cortez D; Schlegel TT; Ackerman MJ; Bos JM
J Electrocardiol; 2017; 50(2):195-202. PubMed ID: 27839835
[TBL] [Abstract][Full Text] [Related]
40. [Athlete's heart or hypertrophic cardiomyopathy?].
Carré F
Presse Med; 2012 Jun; 41(6 Pt 1):608-12. PubMed ID: 22498101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
